#Medical Device CRO in Argentina | Explore Tumblr Posts and Blogs

deshpandeisha · 4 months

Text

Exploring New Horizons: Clinical Trial Software

Clinical trial software refers to specialized computer programs and digital platforms designed to facilitate and optimize various aspects of the clinical trial process. These software solutions are tailored to the unique needs of researchers, clinicians, pharmaceutical companies, and other stakeholders involved in conducting clinical trials.

Clinical trial software Market Size – USD 900.3 Million in 2020, Market Growth – at a CAGR of 15.6%, Market Trends –Increasing focus on decentralized or virtual clinical trials

Request a Sample Report with Table of Contents and Figures to click Here: https://www.emergenresearch.com/request-sample/766

Competitive Terrain:

The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Clinical Trial Software market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.

The leading market contenders listed in the report are:

Medidata Solutions Inc., International Machine Business Corporation (IBM), Oracle Corporation, Parexel International Corp., RealTime Software Solutions LLC, BioClinica Inc., MasterControl Inc., MedNet Solutions Inc., Veeva Systems Inc., and ArisGlobal LLC

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/clinical-trial-software-market

Emergen Research has segmented the global Clinical Trial Software market on the basis of type, application, end-use, and region:

Segments Covered in this report are:

Deployment Outlook (Revenue, USD Million; 2018–2028)

On-Cloud

On-Premises

Delivery Outlook (Revenue, USD Million; 2018–2028)

Web-Based

Licensed Enterprise (On-Premise)

Software as a Service (SAAS)

End-use Outlook (Revenue, USD Million; 2018–2028)

Pharmaceutical & Biotechnology Companies

Contract Research Organizations (CROs)

Medical Device Manufacturers

Others

The various regions analyzed in the report include:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Key Objectives of the Report:

Analysis and estimation of the Clinical Trial Software Market size and share for the projected period of 2022-2028

Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape

Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Clinical Trial Software Market

Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments

Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/766

0 notes

bharat059 · 11 months

Text

Contract Logistics Market 2023-2031 Increasing Demand With SWOT Analysis and Growth Strategies by Top Companies

Contract Logistics Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries covers and analyzes the potential of the global Contract Logistics industry, providing statistical information about market dynamics, growth factors, major challenges, PEST analysis and market entry strategy Analysis, opportunities and forecasts. The biggest highlight of the report is to provide companies in the industry with a strategic analysis of the impact of COVID-19. At the same time, this report analyzed the market of leading 20 countries and introduce the market potential of these countries. “Contract Logistics market was estimated at USD 282542.93 million, and it’s anticipated to reach USD 425815.91 million in 2031, with a CAGR of 4.66% during the forecast years.”

Get a Sample Copy of the Report at –

Segment by Type

Outsourcing

Insourcing

Which growth factors drives the Contract Logistics market growth?

Increasing use of is expected to drive the growth of the Contract Logistics Market.

Segment by Application

Aerospace

Automotive

High-Tech

Pharma & Healthcare

Retail

Others

Market Segment by Region/Country Including: -

North America (United States, Canada, and Mexico)

Europe (Germany, UK, France, Italy, Russia and Spain, etc.)

Asia-Pacific (China, Japan, Korea, India, Australia, Southeast Asia, etc.)

South America (Brazil, Argentina, Colombia, etc.)

Middle East & Africa (South Africa, UAE, Saudi Arabia, etc.)

For More Related Reports Click Here :

Premium Pram and Baby Stroller Market Share

Ionomer for Construction Industry Growth Report

Gastrointestinal Stent Market Statistics

Work Stress Management Industry Forecast

Stabilizers Used in Antibody Drugs and Vaccines Market Size

Vehicle Retarder Market Share

Medical Billing Outsourcing Market

Hearing Protection Devices Market Trends

Spherical Silica Powder Industry Size

Anionic Dispersants Market Forecast

Burn Treatment Anti-Infectives Products Market Forecast

Semiconductor Packaging And Assembly Equipment Market Revenue

Polybutylene Terephthalate (PBT) Industry Forecast

Electric Vehicles Fuel Cell Industry Growth

Biopharmaceutical CMO and CRO Market Share

Soft Exoskeleton (Exosuits) and Wearable Robots Market Trends

Biopharmaceutical CMO and CRO Market Share

Electronics Adhesives Market Trends

Premium Motorcycle Helmet Market Trends

Microplate Reader Market Trends

0 notes

rohans18 · 1 year

Text

Preclinical CRO Market CAGR, Trends, Top Players, Analysis, Industry Size - Forecast 2028

Global Preclinical CRO Market, By Type (Bioanalysis & DMPK Studies, Toxicology Testing, Others), End-Users (Biopharmaceutical Companies, Government and Academic Institutes, Medical Device Companies, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.

An expert team performs systematic, object-oriented and complete market research study to provide the facts associated with any subject in the field of marketing via Preclinical CRO marketing report. The report has a lot to offer to both established and new players in the Preclinical CRO industry with which they can completely understand the market. SWOT analysis and Porter’s Five Forces analysis methods are used wherever applicable, while generating this report. One of the most important parts of an international Preclinical CRO market report is competitor analysis with which businesses can estimate or analyse the strengths and weaknesses of the competitors.

Key Players

The major players covered in the global preclinical CRO market report are Envigo, WuXi AppTec, PPD Inc., Medpace, Charles River Laboratories, PRA Health Sciences, Eurofins Scientific, and Laboratory Corporation of America Holdings among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Browse More Info @ https://www.databridgemarketresearch.com/reports/global-preclinical-cro-market

With the help of credible Preclinical CRO market analysis report, businesses can make out the reaction of the consumers to an already existing product in the market. The report includes estimations of recent state of the market, CAGR values, market size and market share, revenue generation, and necessary changes required in the future products. A wide-ranging competitor analysis helps build superior strategies of production, improvement in certain product, its advertising or marketing and promotion for the business. Exhaustive and comprehensive market study performed in the wide ranging Preclinical CRO market report offers current and forthcoming opportunities that put light on the future market investment.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Preclinical CRO Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Global Market

Part 04: Global Market Size

Part 05: Global Market Segmentation By Product

Part 06: Five Forces Analysis

More Reports:

Diuretic Drugs Market

Patient Engagement Technology Market

Healthcare Business Intelligence Market

Chinese Hamster Ovary cells (CHO) Market

Anti-cancer Drug Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

0 notes

marketresearch-articles · 2 years

Text

Internet of Things (IoT) Healthcare Market Size, Scope, Growth, Competitive Analysis

Internet of Things (IoT) Healthcare Market is grow at a CAGR 18.27% in the forecast 2021 to 2028.

Internet of Things (IoT) Healthcare Market Scope and Size

· On the basis of component, the internet of things (IoT) healthcare market is segmented into medical devices, systems and software and services. Medical devices segment is sub-segmented into wearable external medical devices, implanted medical devices and stationary medical devices. Systems and software segment is sub-segmented into remote device management, network bandwidth management, data analytics, application security and network security. Services segment is sub-segmented into system integration services, professional services and support and maintenance services

· On the basis of application, the internet of things (IoT) healthcare market is segmented into telemedicine, clinical operations and workflow management, connected imaging, inpatient monitoring, medication management and others. Telemedicine segment is sub-segmented into store-and-forward telemedicine, remote patient monitoring and interactive telemedicine.

· On the basis of connectivity technology, the internet of things (IoT) healthcare market is segmented into Wi-Fi, Bluetooth low energy (BLE), zigBee, near field communication (NFC), cellular and satellite.

· On the basis of end user, the internet of things (IoT) healthcare market is segmented into hospitals, surgical centres, and clinics, clinical research organization (CRO), government and defense institutions, research and diagnostics laboratories and others.

Get the sample copy of Report here https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-internet-of-things-iot-healthcare-market

Internet of Things (IoT) Healthcare Market Country Level Analysis

The internet of things (IoT) healthcare market is analysed and market size, volume information is provided by country, component, application, connectivity technology and end user as referenced above.

The countries covered in the internet of things (IoT) healthcare market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, Israel, Egypt, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Competitive Landscape and Internet of Things (IoT) Healthcare Market Share Analysis

The internet of things (IoT) healthcare market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to internet of things (IoT) healthcare market.

MAJOR TOC OF THE REPORT

Chapter One: Internet of Things (IoT) Healthcare Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three : Internet of Things (IoT) Healthcare Market Competition, by Players

Chapter Four: Internet of Things (IoT) Healthcare Market Size by Regions

Chapter Five: Internet of Things (IoT) Healthcare Market by Countries

Chapter Six: Europe Internet of Things (IoT) Healthcare Market Revenue by Countries

Chapter Seven: Internet of Things (IoT) Healthcare Market Revenue by Countries

Chapter Eight: South Internet of Things (IoT) Healthcare Market Revenue by Countries

Chapter Nine: Middle East and Internet of Things (IoT) Healthcare Market venue Equipment by Countries

Chapter Ten: Global Internet of Things (IoT) Healthcare Market Segment by Type

Chapter Eleven: Global Internet of Things (IoT) Healthcare Market Segment by Application

Get TOC Details: https://www.databridgemarketresearch.com/toc/?dbmr=global-internet-of-things-iot-healthcare-market

The major players operating in the internet of things (IoT) healthcare market are Cisco Systems, Inc., GENERAL ELECTRIC COMPANY, Medtronic, Microosoft, Alphabet Inc., Apple Inc., SAP, ABB, Huawei Technologies Co. Ltd, Siemens, Hitachi Vantara Corporation, Qualcomm Technologies Inc., Oracle, CARRÉ TECHNOLOGIES INC., Breathometer Inc., Boston Scientific Corporation, Meru Health., Atlas Wearables, Inc., NeuroMetrix, Inc., Honeywell International Inc., VitalConnect., Ekso Bionics, BL Healthcare, Inc., BioSerenity, Preventice Solutions, Inc., Vitls Inc., AliveCor, Inc., Chrono Therapeutics Inc., Lenovo and Koninklijke Philips N.V.

Access Full Report https://www.databridgemarketresearch.com/reports/global-internet-of-things-iot-healthcare-market

About Us:

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

Browse Related Reports@

Global Agricultural fogging machines market

Global agriculture grade zinc chemicals market

Global Agriculture Seeder Market

Global Aluminium Nickel Catalyst Market

0 notes

sanemyamen · 2 years

Text

Sterilization Pouch Market to Witness Excellent Revenue Growth Owing to Rapid Increase in Demand

Advance Market Analytics released a new market study on Global Sterilization Pouch Market Research report which presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. The research study provides estimates for Global Sterilization Pouch Forecast till 2027*.

The packaging is an essential step in the sterile processing of reusable medical devices. The sterilization packaging must allow sterilization of enclosed devices, maintain sterility until opened and provide for aseptic delivery. Sterilization pouches or peel pouches are intended to contain single items. Sterility maintenance or dust covers are protective plastic bags used to help preserve the sterility of an item by protecting it from the environment. A sterilization pouch paper combines a blue film and a medical-grade paper to provide breathability, sterile barrier and an indication of processing.

Key Players included in the Research Coverage of Sterilization Pouch Market are Amcor plc (Australia),Bemis (United States),Berry Global (United States),Mondi (Austria),Bischof+Klein (Germany),3M (United States),Proampac (United States),Smurfit Kappa Group plc (Ireland),Cantel Medical (United States),Cardinal Health (United States)

What's Trending in Market: Increasing Demand for Effective Sterilization

Challenges: Stringent Government Regulations Regarding Healthcare Products

Opportunities: Increasing Demand from Emerging Markets

Market Growth Drivers: Growing Demand from Healthcare Industry

Rising Need for Safe Handling and Storage of Medical Devices

The Global Sterilization Pouch Market segments and Market Data Break Down by Type (Self - sealing sterilization pouches, Heat - sealing sterilization pouches, Paper and Tyvek sterilization pouches, Multiple inner pouches), Distribution Channel (Online, Offline), Industry Vertical (Food & beverages, Healthcare {Clinical Research Organizations (CROs), Pharmaceutical/Biotechnology companies, Hospitals, Other healthcare settings}, Cosmetics, Household goods, Agriculture, Others (veterinary, and Others)

To comprehend Global Sterilization Pouch market dynamics in the world mainly, the worldwide Sterilization Pouch market is analyzed across major global regions. AMA also provides customized specific regional and country-level reports for the following areas. • North America: United States, Canada, and Mexico. • South & Central America: Argentina, Chile, Colombia and Brazil. • Middle East & Africa: Saudi Arabia, United Arab Emirates, Israel, Turkey, Egypt and South Africa. • Europe: United Kingdom, France, Italy, Germany, Spain, Belgium, Netherlands and Russia. • Asia-Pacific: India, China, Japan, South Korea, Indonesia, Malaysia, Singapore, and Australia. Presented By

AMA Research & Media LLP

0 notes

metiresearchinfo · 2 years

Text

TOP 10 COMPANIES IN U.S. REAL WORLD EVIDENCE(RWE)SOLUTIONS MARKET

Real-world evidence (RWE) is clinical evidence gathered via RWD analysis on a medical product’s use and potential benefits or risks. RWE can be produced through various study designs or analyses, including but not limited to randomized trials, large simple trials, pragmatic trials, and observational studies (prospective or retrospective). The role of RWE in drug development is expanding as RWE studies are significantly less expensive and time-consuming than RCTs, providing easier access to long-term effectiveness data and helping overcome some of the feasibility barriers of running RCTs.

RWE is regularly utilized in the drug development & approval process to inform aspects of drug development, such as the natural history and epidemiology of a disease, and provide data on treatment pathways and comparator interventions in clinical practice.

The U.S. RWE Solutions Market is expected to grow at a CAGR of 13.0% from 2021 to 2028 to reach $2.01 billion by 2028.

Here are the Top 10 Companies in U.S.Real World Evidence Solutions Market

IQVIA HOLDINGS INC.

IQVIA provides advanced analytics, technology solutions, and contract research services to the life sciences industry. In October 2016, Quintiles Transnational Holdings Inc. merged with IMS Health Holdings, Inc. and changed its name to Quintiles IMS Holdings, Inc. Further, QuintilesIMS was renamed IQVIA on November 6, 2017, helping healthcare stakeholders find clinical and analytical solutions for their patients through analytics and science.

The company operates through three major business segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides critical information, technology solutions, and real-world solutions and services to life science clients.

The segment specializes in providing access to deep clinical data in oncology, rare diseases, and other specialty areas. The real-world insights provide post-approval/drug utilization studies and disease registries. The company has a direct presence across Buenos Aires (Argentina), Caracas (Venezuela), Los Ruices (Venezuela), and Bangalore (India) through its offices and has approximately 262 offices in 82 countries. The company’s end users include life sciences companies, including pharmaceutical companies, biotechnology companies, devices, diagnostic companies, and consumer health companies.

ICON plc

ICON provides consulting, clinical development, and commercialization services to pharmaceutical, biotechnology, medical device, and government and public health organizations. The group specializes in the strategic development, management, analysis, and programs that support all clinical development stages from compound selection to Phase I-IV clinical studies. The company works with biopharmaceutical and medical device companies to identify, generate, and communicate the clinical, safety, and cost-effectiveness evidence that regulators, payers, and providers demand in the real-world evidence solutions market.

The company has a direct geographic presence through 93 locations across 41 countries, including Ireland, Australia, Japan, Russia, China, India, Canada, the U.S., Mexico, Brazil, Peru, Argentina, South Africa, Italy, Germany, France, the U.K., Turkey, Sweden, Spain, and other countries.

PPD, Inc.

Founded in 1985 and headquartered in North Carolina (U.S.), PPD provides integrated drug development, laboratory, and management lifecycle services to the biopharmaceutical industry. The company operates in two reportable segments: Clinical Development Services and Laboratory Services. The company operates in the real-world evidence solutions market through its pre- and post-approval services subsegment (a part of the Clinical Development Services segment). As a global CRO, the company resources assist in advancing the drug development program and design protocol for post approval, real-world patient observation leading to new ideas and products.

The company offers RWE services to pharmaceutical, biotech, medical device companies, academic, government, and public health organizations. The company’s real-world evidence services mainly cover hematology/oncology and chronic conditions, immuno-oncology, cell and gene therapy, biomarkers, and rare diseases. The company has a direct presence across the U.K., the U.S., Bulgaria, the Philippines, Mexico, Australia, China, and India, through its offices, clinics, and labs. The company operates in the real-world evidence solutions market through its subsidiary Evidera (U.S.).

Clinigen Group plc

Clinigen Group is engaged in providing medicines. The company operates through two business segments: Products and Services. The Services segment offers real-world evidence solutions and services to capture anonymized data to gain unique insights into how patients are diagnosed and treated in a real-world setting.

The company has a strong geographic presence across the U.S, the U.K., Japan, Australia, New Zealand, South Africa, Belgium, Germany, France, and Switzerland through its sales, offices, and warehouses.

Cognizant Technology Solutions Corporation

Cognizant Technology provides IT services, including digital business, digital operations, and digital systems & technology. The company offers services such as digital services and solutions, consulting, application development, systems integration, application testing, application maintenance, infrastructure services, and business process services. The company operates through four reportable segments: Financial Services, Healthcare, Products and Resources, Communications, and Media and Technology. The company provides real-world evidence solutions through its Healthcare segment. The company has a global presence through its offices and operations in more than 85 cities in 35 countries worldwide.

The company has a direct presence through offices and sales across the U.S., the Philippines, Canada, Mexico, India, Australia, China, Japan, Singapore, Thailand, South Africa, Germany, the U.K., France, Italy, Spain, Sweden, Switzerland, the Netherlands, and Poland.

Meticulous Research in its latest publication on U.S. RWE Solutions Market has predicted the growth of 13.0% during the forecast year 2021 to 2028.

IBM Corporation

International Business Machines Corporation (IBM) is a technology organization providing a wide range of consulting and IT implementation services, cloud, digital and cognitive offerings, and enterprise systems and software. The company operates through five key business segments: Cloud & Cognitive Software, Global Business Services, Global Technology Services, Systems, and Global Financing. The Global Business Services segment provides clients with consulting, business processes, and application management services and has several IBM units, such as IBM Watson, IBM Cloud, IBM Research, and Global Technology Services. IBM Watson is a leading provider of innovative cognitive, analytics, security, and cloud technology in comprehensive industryspecific platforms to remove much of the cost and complexity of delivering core business functions. In the real-world evidence solutions market, IBM Watson offers a cloud-based solution that allows users to explore, analyze, visualize, and share real-world outcomes on healthcare data from proprietary datasets.

IBM has a global presence, operating in more than 175 countries with a broad-based geographic distribution of revenue. The company has a geographic presence across India, France, Brazil, China, Canada, U.S., Germany, the U.K., Italy, Australia, and the Middle East and Africa through its sales, distribution, business channels, and service offerings

SAS Institute Inc.

Founded in 1976 and headquartered in North Carolina (U.S.), SAS Institute provides analytics, business intelligence, and data management software & services. The company serves its solutions for different industry verticals: automotive, banking, capital markets, casinos, communication, healthcare, health insurance, and life sciences, among others. The company operates in the real-world evidence solutions market by offering real-world evidence consulting services.

SAS has customers in 147 countries and has a strong geographic presence across the U.S., Canada, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. The company’s software is installed at more than 83,000 business, government, and university sites.

UnitedHealth Group Incorporated

Incorporated in 1977 and headquartered in Minnesota (U.S.), UnitedHealth Group is a diversified healthcare company with four reportable segments across two business platforms: UnitedHealthcare (health benefits) and Optum (health services). The Optum segment has dedicated units that help improve overall health system performance by optimizing care quality, reducing costs, improving consumer experience and care provider performance, and leveraging distinctive capabilities in data and analytics, pharmacy care services, population health, health care delivery, and health care operations. Optum operates through three business segments: OptumHealth, OptumInsight, and OptumRx.

The company offers fully integrated services that comprise behavioral health, preventive services, and digital engagement. Optum offers a real-world data health analytics platform and consulting services. The company offers services in more than 150 countries and has a strong geographical presence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Oracle Corporation

Oracle is engaged in providing products and services that address all aspects of corporate information technology (IT) environments—applications, platforms, and infrastructure. The company operates through three business segments: Cloud License, Hardware, and Services. The company provides solutions for the real-world evidence solutions market through its Services segment. The Services segment provides services to maximize their investments in Oracle applications, platforms, and infrastructure technologies. Oracle Health Sciences offers real-world evidence solutions for clinical data managers, biostatisticians, and data scientists. With its subsidiaries and a strong distribution network, the company has its presence across India, the U.S., Canada, Mexico, Argentina, Brazil, Peru, and Australia.

PAREXEL International Corporation

Parexel is engaged in providing clinical research and logistics, medical communications, consulting, commercialization, and advanced technology products and services for pharmaceutical, biotechnology, and medical device industries worldwide. The company operates in three business segments: Clinical Research Services, Parexel Consulting Services, and Parexel Informatics. The access unit of Clinical Research Services provides Real-World Evidence solutions.

The company has a strong geographic presence across the U.S., Mexico, Argentina, Brazil, Denmark, Czech Republic, Poland, the Netherlands, Belgium, Russia, Spain, France, Germany, U.K., Sweden, Switzerland, Australia, Korea, Singapore, India, Thailand, Indonesia, Japan, China, Malaysia, and the Middle East & Africa. In June 2017, Parexel International Corporation was acquired by Pamplona Capital Management LLC. (U.S.) for USD 5 billion.

Popular Mentions: PerkinElmer, Inc., Flatiron Health, SYNEOS HEALTH, INC., CLARIVATE PLC, Medpace Holdings, Inc., Symphony Innovation, LLC, Veeva Systems Inc., Sensyne Health, Prognos Health Inc., HealthVerity Inc., and Truveta Inc.

Amidst this crisis, Meticulous Research® is continuously assessing the impact of COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to assess the impact of COVID-19 on any industry here- https://www.meticulousresearch.com/custom-research

Authoritative Research on the U.S. RWE Solutions Market – Global Opportunity Analysis and Industry Forecast (2021-2028)

Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:

Recent financial performance

Key products

Significant company strategies

Partnerships and acquisitions

Impact of COVID-19

The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.

Please download report pages and learn more: https://www.meticulousresearch.com/download-sample-report/cp_id=5243

0 notes

healthcaremarketreports2022 · 2 years

Text

Clinical Trial Imaging Market Size was Valued at USD 963 Million in 2020 and is Projected to Reach USD 1,518 Million by 2028.

Global Clinical Trial Imaging Market is growing at a CAGR of 5.9% from 2021 to 2028.Clinical trial imaging makes use of imaging technology in clinical trials for seeing the interior parts of the body. The images obtained from clinical trial imaging are used to examine drug activity. Clinical trial imaging provides rapid, detail, and precise screening. The use of clinical trial imaging has rapidly increased in all phases of the clinical trials. Medical imaging in clinical trials is used as a primary, quantitative, and surrogate biomarker.

Clinical trials are an important part of the drug development process. However, the cost of conducting clinical trials has increased in recent years. Therefore, clinical trial imaging is emerging as an alternative measure that can help reduce the cost of the drug trial and thus improve the timeline of clinical trials. Increasing the use of the technology along with enhanced power of computing is boosting the usage of imaging in clinical trials. The Quantitative Imaging Biomarkers Alliance (QIBA) protocol offers standardized methods as well as imaging procedures with uniform procedures that can be implemented to attain precise and statistical endpoints in clinical trials.

Request a free sample copy or view report summary: https://healthcaremarketreports.com/sample-request/clinical-trial-imaging-market/48/

Global Clinical Trial Imaging Market: Top Key Players

Cardiovascular Imaging Technologies, LLC

Radiant Sage LLC

Biotelemetry, Inc.

Intrinsic Imaging LLC

Ixico PLC

Icon PLC

Worldcare Clinical, LLC

Biomedical Systems Corporation

Parexel International Corporation

Bioclinica, Inc.

Global Clinical Trial Imaging Market: By Types

Trial Design Consulting Services

Read Analysis Services

Operational Imaging Services

Global Clinical Trial Imaging Market: By Applications

Pharmaceutical & Biotechnology Companies

Medical Device Manufacturers

Contract Research Organizations

Academic and Government Research Institutes

Global Clinical Trial Imaging Market: By Countries

United States,Canada,Germany,UK,France,Italy,Spain,Russia,China,Japan, South Korea,Australia,Thailand,Brazil,Argentina,Chile,South Africa,Egypt, UAE,Saudi Arabia

Global Clinical Trial Imaging Market Overview

Medical imaging plays an active role in the clinical development of novel life science products. Although the medical imaging industry is in a constant state of fluctuation, the biotechnology and pharmaceutical industries continue to increase. This can be attributed to enhanced investment in medical imaging companies as well as mergers and acquisitions along with the adoption of innovative imaging technologies to support clinical trials for medical devices. However, the high cost of machinery and their installation and high capital required to run clinical trials can restrain the growth of the market.

Get Discount on This Report: https://healthcaremarketreports.com/discount/clinical-trial-imaging-market/48/

Clinical Trial Imaging Market Report Highlights

· Based on service, project and data management services held the largest share in 2020 due to the growing requirement of data management and workflow for clinical trial imaging

· Operational imaging services held a significant share in 2020. They include imaging modalities such as MRI, CT scan, X-ray, ultrasound, OCT, PET, and SPECT. CT scan modality is gaining popularity due to its non-invasive nature and its ability to provide detailed information about the disease for enhanced treatment

· The others application segment held the largest share in 2020. This segment includes oncology, neurology, and musculoskeletal. Market players such as ICON, Bioclinica, Navitas Life Sciences, and Paraxel International are developing their clinical trial imaging services for these applications

· By end-use, CROs held the largest share in 2020 due to increasing investments in the field of research and development and snowballing outsourcing activities by the pharmaceutical and biotechnology companies to cut down the cost and time and patent expiration

· North America dominated the market in 2020 due to the increasing geriatric population, rising chronic diseases, and growing demand for treatment options

About Us:

The healthcare industry is surely facing disruptions with global economies giving high importance to individual health. In this scenario, we expect our clients to get deep insights to power their innovations in the right direction. We have been keeping a close watch on the changes and modifications happening in the healthcare domain. As per our understanding, these alterations are active and unexampled.

healthcare Market Reports

[email protected]

+1(929)-450-2887

#Global Clinical Trial Imaging Market

0 notes

sorav93 · 3 years

Text

Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 2022-2028 Size, Share, Trend, Key Palyers with Products

Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 2022-2028

A New Market Study, Titled “Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Upcoming Trends, Growth Drivers and Challenges” has been featured on fusionmarketresearch.

Description

This global study of the Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market offers an overview of the existing market trends, drivers, restrictions, and metrics and also offers a viewpoint for important segments. The report also tracks product and services demand growth forecasts for the market. There is also to the study approach a detailed segmental review. A regional study of the global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) industry is also carried out in North America, Latin America, Asia-Pacific, Europe, and the Near East & Africa. The report mentions growth parameters in the regional markets along with major players dominating the regional growth.

Request Free Sample Report @ https://www.fusionmarketresearch.com/sample_request/2021-2030-Report-on-Global-Pharmaceutical-Contract-Development-and-Manufacturing-Organization-(CDMO)-Market/70129

This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Leading players of Pharmaceutical Contract Development and Manufacturing Organization (CDMO) including: LabCorp IQVIA Syneos Health Quintiles PPD Parexel ICON PRA Health Sciences InVentiv INC Research Holdings CRL Wuxi AppTec Charles River Envigo Medpace Holdings SGS PSI CRO Axcent Advanced Analytics BIO Agile Therapeutics Firma Clinical Research Acculab Lifesciences Azelix CTSERV PEPGRA Dove Quality Solutions

Market split by Type, can be divided into: Preclinical CRO Clinical Trial CRO Others

Market split by Application, can be divided into: Pharmaceutical & Biopharmaceutical Companies Medical Device Companies Academic Institutes

Market split by Sales Channel, can be divided into: Direct Channel Distribution Channel

Market segment by Region/Country including: North America (United States, Canada and Mexico) Europe (Germany, UK, France, Italy, Russia and Spain etc.) Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.) South America (Brazil, Argentina and Colombia etc.) Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)

Ask Queries @ https://www.fusionmarketresearch.com/enquiry.php/2021-2030-Report-on-Global-Pharmaceutical-Contract-Development-and-Manufacturing-Organization-(CDMO)-Market/70129

Table of Contents

Chapter 1 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Overview 1.1 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Definition 1.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size Status and Outlook (2015-2030) 1.3 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size Comparison by Region (2015-2030) 1.4 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size Comparison by Type (2015-2030) 1.5 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size Comparison by Application (2015-2030) 1.6 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size Comparison by Sales Channel (2015-2030) 1.7 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Dynamics (COVID-19 Impacts) 1.7.1 Market Drivers/Opportunities 1.7.2 Market Challenges/Risks 1.7.3 Market News (Mergers/Acquisitions/Expansion) 1.7.4 COVID-19 Impacts on Current Market 1.7.5 Post-Strategies of COVID-19 Outbreak

Chapter 2 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Segment Analysis by Player 2.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Market Share by Player (2018-2020) 2.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Revenue and Market Share by Player (2018-2020) 2.3 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Average Price by Player (2018-2020) 2.4 Players Competition Situation & Trends 2.5 Conclusion of Segment by Player

Chapter 3 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Segment Analysis by Type 3.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market by Type 3.1.1 Preclinical CRO 3.1.2 Clinical Trial CRO 3.1.3 Others 3.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Sales and Market Share by Type (2015-2020) 3.3 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Revenue and Market Share by Type (2015-2020) 3.4 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Average Price by Type (2015-2020) 3.5 Leading Players of Pharmaceutical Contract Development and Manufacturing Organization (CDMO) by Type in 2020 3.6 Conclusion of Segment by Type

Chapter 4 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Segment Analysis by Application 4.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market by Application 4.1.1 Pharmaceutical & Biopharmaceutical Companies 4.1.2 Medical Device Companies 4.1.3 Academic Institutes 4.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Revenue and Market Share by Application (2015-2020) 4.3 Leading Consumers of Pharmaceutical Contract Development and Manufacturing Organization (CDMO) by Application in 2020 4.4 Conclusion of Segment by Application

Continue…

ABOUT US:

Fusion Market Research is one of the largest collections of market research reports from numerous publishers. We have a team of industry specialists providing unbiased insights on reports to best meet the requirements of our clients. We offer a comprehensive collection of competitive market research reports from a number of global leaders across industry segments.

[email protected]

Phone: + (210) 775-2636 (USA) + (91) 853 060 7487

0 notes

adityarana1687-blog · 3 years

Text

Clinical Trial Management System To Touch New Height USD 1.62 Billion By 2025

The global clinical trials management system (CTMS) market size is expected to reach USD 1.62 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 12.1% over the forecast period. Rapid growth of healthcare IT, high R&D expenditure by life science and clinical research organizations, and adoption of CTMS solutions is anticipated to drive the market growth.

Increasing investment by pharmaceutical and biotechnology companies coupled with government funding is promoting research activities. This factor is expected to boostgrowth of the market for clinical trial management systems.According to the estimates of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), global research-based pharmaceutical industry has spent around USD 149.8 billion in 2015. The annual spending of pharmaceutical industry is 5.5 times greater than the aerospace industry, 1.8 times more than software and computer services andsoftware industry, and 5 times more than chemicals industry.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/clinical-trial-management-system-ctms-market

Further key findings from the report suggest:

Enterprise CTMS held the largest market share in 2016 due to the benefits such as real-time insight into operational activities and efficient tracking in tracking and managing the regulatory process

Web-based systems held the largest market share in 2016 owing to the benefits such as remote access of data and minimal technical issues

Cloud based system is anticipated to exhibit the fastest CAGRover the forecast period. Real-time data tracking, high security, easy accessibility from any device, and privacy are a few factors attributed to the growth

Based onregion, North America is expected to continue holding the largest market share during the forecast period due to high adoption of advanced technology and improved healthcare infrastructure

Asia Pacificis likely to witness significant growthover the next decade due toincreasing government incentives and low cost of clinical trials

Some of the key players operating in the Clinical Trials Management System (CTMS) market are Surgery Partners;PARAXEL International Corporation; Oracle Corporation; Medidata Solutions Inc.; Forte Research Systems Inc.; Medpace Holdings Inc.; and Clinical Data Inc.

Grand View Research has segmented the global Clinical Trials Management System (CTMS) market based on type, delivery mode, component, end user, and region:

Clinical Trials Management System (CTMS) Type Outlook (Revenue, USD Million, 2014 - 2025)

Enterprise

Site

Clinical Trials Management System (CTMS) Delivery Mode Outlook (Revenue, USD Million, 2014 - 2025)

Web-based

Cloud-based

On-Premise

Clinical Trials Management System (CTMS) Component Outlook (Revenue, USD Million, 2014 - 2025)

Software

Services

Clinical Trials Management System (CTMS) End-User Outlook (Revenue, USD Million, 2014 - 2025)

Pharmaceutical and Biotechnology Firm

CROs

Medical Device Firm

Johnson & Johnson

Roche

Novartis

Pfizer

Merck

GlaxoSmithKline

Novo Nordisk

Amgen

Bristol Myesr Squibb

Sanofi

Clinical Trials Management System (CTMS) Regional Outlook (Revenue, USD Million, 2014 - 2025)

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

U.S.

Canada

Germany

U.K.

France

Italy

Spain

Russia

Belgium

Netherlands

Japan

China

India

Thailand

Australia

Singapore

Malaysia

Indonesia

South Korea

Philippines

Brazil

Mexico

Argentina

South Africa

Saudi Arabia

United Arab Emirates

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

#Clinical Trial Management System

0 notes

bioaccessla · 6 months

Text

Bioaccess provides the best medical device CRO services in Costa Rica! With extensive experience and a proven track record, we offer comprehensive support throughout the product development lifecycle. From regulatory consulting to clinical trial management, our team ensures efficient and successful outcomes for your medical device. Trust us as your partner in innovation and accelerate your path to market approval. Contact us today to learn more about our tailored CRO services and propel your project forward! www.bioaccessla.com

1 note · View note

press-release-dash · 3 years

Text

CT Scanner Market 2021 | Business Opportunity, Growth Strategies & Forecast Report By 2027

The Global CT Scanner Market Report, in its latest update, highlights the significant impacts and the recent strategically changes under the present socio-economic scenario. The CT Scanner industry growth avenues are deeply supported by exhaustive research by the top analysts of the industry. The report starts with the executive summary, followed by a value chain and Marketing channels study. The report then estimates the CAGR and Market revenue of the global and regional segments.

Base Year: 2020

Estimated Year: 2021

Forecast Till: 2027

The report classifies the market into different segments based on type and product. These segments are studied in detail, incorporating the market estimates and forecasts at regional and country levels. The segment analysis is helpful in understanding the growth areas and potential opportunities of the market.

Get | Download FREE Sample Report of Global CT Scanner Market @ https://www.decisiondatabases.com/contact/download-sample-1536

A special section is dedicated to the analysis of the impact of the COVID-19 pandemic on the growth of the CT Scanner market. The impact is closely studied in terms of production, import, export, and supply.

The report covers the complete competitive landscape of the Worldwide CT Scanner market with company profiles of key players such as:

General Healthcare

Siemens

Philips

Toshiba Corporation

Hitachi

Shimadzu

Samsung

Neusoft Medical Systems

Medtronic

Shenzhen

Accuray

Want to add more Company Profiles to the Report? Write your Customized Requirements to us @ https://www.decisiondatabases.com/contact/get-custom-research-1536

CT Scanner Market Analysis by Type:

Stationary CT Scanners

Portable CT Scanners

CT Scanner Market Analysis by By Device Architecture

C-Arm CT Scanners

O-Arm CT Scanners

CT Scanner Market Analysis by By Technology

High-Slice CT

Mid-Slice CT

Low-Slice CT

Cone Beam CT (CBCT)

CT Scanner Market Analysis by By Application

Human Applications

Diagnostic Applications

Intraoperative Applications

Veterinary Applications

Research Applications

Cardiology Applications

Oncology Applications

Neurology Applications

Other Diagnostic Applications

CT Scanner Market Analysis by By End User

Hospitals and Diagnostic Centers

Research Laboratories, Academic Institutes

Cros Ambulatory Care Centers

Veterinary Clinics and Hospitals

CT Scanner Market Analysis by Geography:

North America (USA, Canada, and Mexico)

Europe (Germany, UK, France, Italy, Russia, Spain, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Australia, South-East Asia, Rest of Asia-Pacific)

Latin America (Brazil, Argentina, Peru, Chile, Rest of Latin America)

The Middle East and Africa (Saudi Arabia, UAE, Israel, South Africa, Rest of the Middle East and Africa)

Key questions answered in the report:

What is the expected growth of the CT Scanner market between 2022 to 2027?

Which application and type segment holds the maximum share in the Global CT Scanner market?

Which regional CT Scanner market shows the highest growth CAGR between 2022 to 2027?

What are the opportunities and challenges currently faced by the CT Scanner market?

Who are the leading market players and what are their Strengths, Weakness, Opportunities, and Threats (SWOT)?

What business strategies are the competitors considering to stay in the CT Scanner market?

Purchase the Complete Global CT Scanner Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-1536

About Us:

DecisionDatabases.com is a global business research report provider, enriching decision-makers, and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research reports, customized research reports, company profiles, and industry databases across multiple domains. Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise, and meaningful data at a lightning speed.

For more details: DecisionDatabases.com E-Mail: [email protected] Phone: +91 90 28 057900 Web: https://www.decisiondatabases.com/

#CTScannerMarket #CTScannerMarketReport #CTScannerMarketSize

0 notes

rohans18 · 1 year

Text

Preclinical CRO Market Trends, Share

The consistent Preclinical CRO market report analyzes many points that help businesses to solve the toughest questions in less time. The major topics of this business report are global growth trends, market share by manufacturers, market size by type, market size by application, production by region, consumption by region, company profiles, market forecast, value chain and sales channels analysis, opportunities & challenges, threat and affecting factors. The report gives market definition in the form of market driving factors and market restraints which helps estimating the demand of particular product depending on several aspects. Preclinical CRO market survey report studies the global market status and forecast, categorizes the global market size, market value & market volume by key players, type, application, and region.

Key Players

Browse More Info @ https://www.databridgemarketresearch.com/reports/global-preclinical-cro-market

One of the principal objectives of a high-ranking Preclinical CRO industry report is to analyze and study the global sales, value, status, and forecast. The market report also analyzes the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. The report assists to define, describe and forecast the market by type, application and region. It estimates the region that is foretold to create the most number of opportunities in the global Preclinical CRO market. This market research report comprises of estimations of CAGR values which are quite significant and aids businesses to decide upon the investment value over the time period. An insightful Preclinical CRO market report assists clients to stay ahead of the time and competition.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Preclinical CRO Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Global Market

Part 04: Global Market Sizing